Mr Eugene Wayne Tsai, MD | |
12225 South St, #102, Artesia, CA 90701-7053 | |
(562) 865-2402 | |
(562) 865-6621 |
Full Name | Mr Eugene Wayne Tsai |
---|---|
Gender | Male |
Speciality | Allergy/immunology |
Experience | 26 Years |
Location | 12225 South St, Artesia, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053301200 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207K00000X | Allergy & Immunology | A70444 (California) | Primary |
Entity Name | Eugene W Tsai Md A Professional Medical Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1134453392 PECOS PAC ID: 2860623758 Enrollment ID: O20140318000038 |
News Archive
Large quantities of antibiotic-resistant bacteria enter the environment via municipal - and especially hospital - wastewater streams. Although wastewater treatment plants reduce the total number of bacteria, the most hazardous - multiresistant - strains appear to withstand or even to be promoted by treatment processes. This was demonstrated by Eawag researchers in a study carried out in Lake Geneva, near Lausanne.
According to the U.S. Agency for Healthcare Research and Quality (AHRQ), compared to men in 1999, American men in 2006 that were fighting prostate cancer were 45% less likely to die from the disease.
Accumetrics, Inc. has announced the signing of a new exclusive distribution agreement for its VerifyNow(R) System in Spain, Portugal and Chile with Grifols S.A.. This distribution agreement will continue to expand Accumetrics' reach in both scope and geography, and add to the growing numbers of countries where physicians have access to the VerifyNow System.
FiatLux Imaging, Inc., a company dedicated to the development of powerful and useful new software to make the practice of medicine more effective, less expensive and more timely, announced today that, due to user demand and rapidly expanding use, it is extending the free availability of its Visualize FREE application for reading and analyzing medical imaging studies.
The widespread incidence of drug-resistant tuberculosis (TB) "calls for a new approach to TB in the developing world," a Bloomberg editorial states.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Mr Eugene Wayne Tsai, MD 12225 South St, #102, Artesia, CA 90701-7053 Ph: (562) 865-2402 | Mr Eugene Wayne Tsai, MD 12225 South St, #102, Artesia, CA 90701-7053 Ph: (562) 865-2402 |
News Archive
Large quantities of antibiotic-resistant bacteria enter the environment via municipal - and especially hospital - wastewater streams. Although wastewater treatment plants reduce the total number of bacteria, the most hazardous - multiresistant - strains appear to withstand or even to be promoted by treatment processes. This was demonstrated by Eawag researchers in a study carried out in Lake Geneva, near Lausanne.
According to the U.S. Agency for Healthcare Research and Quality (AHRQ), compared to men in 1999, American men in 2006 that were fighting prostate cancer were 45% less likely to die from the disease.
Accumetrics, Inc. has announced the signing of a new exclusive distribution agreement for its VerifyNow(R) System in Spain, Portugal and Chile with Grifols S.A.. This distribution agreement will continue to expand Accumetrics' reach in both scope and geography, and add to the growing numbers of countries where physicians have access to the VerifyNow System.
FiatLux Imaging, Inc., a company dedicated to the development of powerful and useful new software to make the practice of medicine more effective, less expensive and more timely, announced today that, due to user demand and rapidly expanding use, it is extending the free availability of its Visualize FREE application for reading and analyzing medical imaging studies.
The widespread incidence of drug-resistant tuberculosis (TB) "calls for a new approach to TB in the developing world," a Bloomberg editorial states.
› Verified 4 days ago